Fundraising FoxVariation Biotechnologies (US)
Cambridge, US
Find your way into Variation Biotechnologies (US)
Sign up to see every warm intro you have to Variation Biotechnologies (US)
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Variation Biotechnologies (US) team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
EN
Egidio NascimentoExecutive
JB
Jeff BaxterExecutive
Board
SG
Steve GillisBoard director
SV
Steven VignauBoard director
MS
Michael SteinmetzBoard director
SR
Scott RocklageBoard director
Reported raises · per SEC filings
Form D private placements$3.7M disclosed across 2 rounds · 2011–2014
▶$1.5MraisedMar 2014 · 8 investors · BiotechnologyRule 506(b)
▶$1.5MraisedMar 2014 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David E. AndersonExecutive Officer
- Stephen GillisDirector
- Steve VignauDirector
- Michael SteinmetzDirector
- Egidio NascimentoExecutive Officer
- Jeff BaxterExecutive Officer, Director
- Kevin ForrestDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Sales commissions
- $65K
- Proceeds to insiders
- $250K
- Placement agents
- Palladium Capital Advisors, LLC, Middlebury Securities, LLC
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedFeb 2012 · 4 investors · BiotechnologyRule 506(b)
▶$2.2MraisedFeb 2012 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Egidio NascimentoExecutive Officer
- Steve GillisDirector
- Jeff BaxterExecutive Officer, Director
- Steven VignauDirector
- Michael SteinmetzDirector
- Scott RocklageDirector
- Offering amount
- $2.2M
- Amount sold
- $2.2M
- First sale
- Dec 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Variation Biotechnologies (US) raised?
- Variation Biotechnologies (US) has disclosed $3.7M raised across 2 rounds.
- Where is Variation Biotechnologies (US) headquartered?
- Variation Biotechnologies (US) is headquartered in Cambridge, US.